Search Press releases

23 Aug 2024

Transparency notification BlackRock, Inc.

Read More
21 Aug 2024

Transparency notification BlackRock, Inc.

Read More
9 Aug 2024

Transparency notification Goldman Sachs

Read More
8 Aug 2024

Transparency notification Goldman Sachs

Read More
7 Aug 2024

Transparency notification Goldman Sachs

Read More
5 Aug 2024

UCB announces European Commission approval for 320 mg device presentations of BIMZELX[®]▼(bimekizumab)

Read More

Stay up-to-date on the latest news and information from UCB